世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

デジタル糖尿病管理市場の市場規模、シェア、動向分析レポート:製品別(持続血糖モニタリングシステム、スマートインスリンペン)、タイプ別、最終用途別、地域別、セグメント別予測、2023年~2030年


Digital Diabetes Management Market Size, Share & Trends Analysis Report By Product (Continuous Blood Glucose Monitoring System, Smart Insulin Pen), By Type, By End-use, By Region, And Segment Forecasts, 2023 - 2030

デジタル糖尿病管理市場の成長と動向 Grand View Research, Inc.の最新レポートによると、世界のデジタル糖尿病管理市場規模は、2023年から2030年にかけて年平均成長率8.3%で拡大し、2030年には219億米ドルに... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
Grand View Research
グランドビューリサーチ
2023年10月3日 US$5,950
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
110 英語

本レポートは受注生産のため、ご納品のお時間をいただく場合がございます。


 

サマリー

デジタル糖尿病管理市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のデジタル糖尿病管理市場規模は、2023年から2030年にかけて年平均成長率8.3%で拡大し、2030年には219億米ドルに達する見込みです。市場成長の主な要因は、世界的な糖尿病罹患率の増加、製品発売数の増加、予測分析や人工知能(AI)などの技術革新である。

データ分析と人工知能は、今や糖尿病患者向けのデジタル・ソリューションに不可欠な要素となっている。AIは、大量の患者情報を活用できることから、急速に注目を集めている。デジタル糖尿病管理ツールは、患者のグルコースレベルとパターンの分析を支援する。また、患者が食事摂取量やインスリン投与量を決定するのにも役立つ。疾病管理用のスマートフォンアプリの数はここ数年で飛躍的に増加しており、市場を大きく後押ししている。例えば、2019年9月、アボット社はサノフィ社と非独占的パートナーシップを締結し、クラウド接続型インスリンペン(サノフィ社)とFreeStyle Libreモバイルアプリケーション(アボット社)を統合し、糖尿病の管理プロセスを容易にした。

市場の成長は、肥満の有病率の増加、高齢化人口の増加、糖尿病予防医療に関する意識の高まりによってさらに促進される。さらに、スマートデバイスのアクティブユーザー数の増加や、患者が血糖値をモニターできる新しいアプリの発売が市場を牽引している。これらのアプリは、医療専門家のために高度な技術を使用し、患者により良い健康結果を提供する。2019年5月、Roche Diabetes Care Indiaは、Accu-Chek Instant血糖モニタリング(BGM)システムとMy Sugarアプリの発売により、インドにおける統合糖尿病管理ソリューション(IDMS)プログラムを導入した。この組み合わせは、次世代BGMシステムの登場を意味する。これにより、同製品の需要が高まり、同国の市場全体が牽引されることが期待される。

デジタル糖尿病管理市場レポートハイライト

- 製品別では、持続血糖モニタリングセグメントが2022年の市場を支配し、40.6%以上の収益シェアを占める

- スマートインスリンペン製品セグメントは予測期間中最も速いCAGR 11.4%で拡大する

- タイプ別では、ウェアラブルデバイスセグメントが2022年に最大の収益シェアを占め、予測期間中に最も急成長するセグメントとして浮上する可能性が高い

- アプリ製品分野では、デジタル糖尿病管理アプリが2022年に最大の収益シェアを占めた。体重・食事管理アプリは予測期間中に最も速い成長率を示すと予測される

- 北米は2022年に圧倒的な収益シェアを占め、有利な償還政策、主要プレイヤーの存在、政府の支援策により予測期間中も優位性を維持すると予測される。

ページTOPに戻る


目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Type
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Type outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Digital Diabetes Management Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Digital Diabetes Management Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Digital Diabetes Management Market: Product Estimates & Trend Analysis
4.1. Digital Diabetes Management Market: Key Takeaways
4.2. Digital Diabetes Management Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Smart Glucose Meter
4.3.1. Smart glucose meter market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Continuous Blood Glucose Monitoring System
4.4.1. Continuous blood glucose monitoring system market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Smart Insulin Pens
4.5.1. Smart insulin pens market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Smart Insulin Pumps
4.6.1. Smart insulin pumps market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Apps
4.7.1. Apps market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.2. Digital diabetes management apps
4.7.2.1 Digital diabetes management apps market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.3. Weight and diet management apps
4.7.2.2 Weight and diet management apps market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Digital Diabetes Management Market: Type Estimates & Trend Analysis
5.1. Digital Diabetes Management Market: Key Takeaways
5.2. Digital Diabetes Management Market: Type Movement & Market Share Analysis, 2022 & 2030
5.3. Wearable Devices
5.3.1. Wearable devices market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Handheld Devices
5.4.1. Handheld devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Digital Diabetes Management Market: End Use Estimates & Trend Analysis
6.1. Digital Diabetes Management Market: Key Takeaways
6.2. Digital Diabetes Management Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Home Settings
6.4.1. Home settings market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Diagnostic Centers
6.5.1. Diagnostic centers market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Digital Diabetes Management Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Digital Diabetes Management Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Medtronic
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Abbott
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Ascensia Diabetes Care
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. F. Hoffmann-La Roche Ltd.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Bayer AG
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. LifeScan, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. Dexcom, Inc.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Sanofi
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Insulet Corporation
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. B. Braun Melsungen AG
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

 

ページTOPに戻る


 

Summary

Digital Diabetes Management Market Growth & Trends

The global digital diabetes management market size is expected to reach USD 21.9 billion by 2030, expanding at a CAGR of 8.3% from 2023 to 2030, according to a new report by Grand View Research, Inc. Major factors contributing to the market growth are the growing incidences of diabetes globally, the increasing number of product launches, and innovation in technologies such as predictive analytics and artificial intelligence (AI).

Data analytics and artificial intelligence are now an integral part of digital solutions for diabetics. AI is gaining rapid attention due to its ability to harness massive volumes of patient information. Digital diabetes management tools help patients analyze their glucose levels and pattern. They also help patients decide on food intake and dosage of insulin. The number of smartphone apps for disease management has seen a monumental rise over the past few years, giving the market a major boost. For instance, in September 2019, Abbott entered into a non-exclusive partnership with Sanofi to integrate cloud-connected insulin pens (Sanofi) with FreeStyle Libre mobile application (Abbott) to ease the management process of diabetes.

The market growth is further augmented by the increasing prevalence of obesity, the growing aging population, and increasing awareness regarding diabetes preventive care. Moreover, the market is driven by the increasing number of active users of smart devices and the launch of new apps that allow patients to monitor their blood glucose. These apps use advanced technology for health care professionals and provide patients with better health outcomes. In May 2019, Roche Diabetes Care India introduced its Integrated Diabetes Management Solution (IDMS) program in India with the launch of the Accu-Chek Instant blood glucose monitoring (BGM) system and the My Sugar app. The combination marks the entry of the next-generation BGM system. This is expected to propel the demand for the product, thereby driving the overall market in the country.

Digital Diabetes Management Market Report Highlights

• Based on product, the continuous blood glucose monitoring segment dominated the market in 2022, accounting for a revenue share of over 40.6%

• The smart insulin pens product segment will expand at the fastest CAGR of 11.4% during the forecast period

• By type, the wearable devices segment held the largest revenue share in 2022 and is likely to emerge as the fastest-growing segment during the forecast period

• In the apps product segment, digital diabetes management apps accounted for the largest revenue share in 2022. Weight and diet management apps are projected to exhibit the fastest growth rate during the forecast period

• North America held the dominant revenue share in 2022 and is expected to maintain its dominance during the forecast period owing to favorable reimbursement policies, the presence of key players, and supportive government initiatives



ページTOPに戻る


Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Type
1.1.3. End-use
1.1.4. Regional scope
1.1.5. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Type outlook
2.2.3. End-use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Digital Diabetes Management Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market Driver Analysis
3.3.2. Market Restraint Analysis
3.4. Digital Diabetes Management Market Analysis Tools
3.4.1. Industry Analysis - Porter’s Five Forces
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Digital Diabetes Management Market: Product Estimates & Trend Analysis
4.1. Digital Diabetes Management Market: Key Takeaways
4.2. Digital Diabetes Management Market: Product Movement & Market Share Analysis, 2022 & 2030
4.3. Smart Glucose Meter
4.3.1. Smart glucose meter market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Continuous Blood Glucose Monitoring System
4.4.1. Continuous blood glucose monitoring system market estimates and forecasts, 2018 to 2030 (USD Million)
4.5. Smart Insulin Pens
4.5.1. Smart insulin pens market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Smart Insulin Pumps
4.6.1. Smart insulin pumps market estimates and forecasts, 2018 to 2030 (USD Million)
4.7. Apps
4.7.1. Apps market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.2. Digital diabetes management apps
4.7.2.1 Digital diabetes management apps market estimates and forecasts, 2018 to 2030 (USD Million)
4.7.3. Weight and diet management apps
4.7.2.2 Weight and diet management apps market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Digital Diabetes Management Market: Type Estimates & Trend Analysis
5.1. Digital Diabetes Management Market: Key Takeaways
5.2. Digital Diabetes Management Market: Type Movement & Market Share Analysis, 2022 & 2030
5.3. Wearable Devices
5.3.1. Wearable devices market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Handheld Devices
5.4.1. Handheld devices market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Digital Diabetes Management Market: End Use Estimates & Trend Analysis
6.1. Digital Diabetes Management Market: Key Takeaways
6.2. Digital Diabetes Management Market: End-use Movement & Market Share Analysis, 2022 & 2030
6.3. Hospitals
6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. Home Settings
6.4.1. Home settings market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. Diagnostic Centers
6.5.1. Diagnostic centers market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Digital Diabetes Management Market: Regional Estimates & Trend Analysis
7.1. Regional Outlook
7.2. Digital Diabetes Management Market by Region: Key Takeaways
7.3. North America
7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.2. U.S.
7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.3.3. Canada
7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4. Europe
7.4.1. UK
7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.2. Germany
7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.3. France
7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.4. Italy
7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.5. Spain
7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.6. Denmark
7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.7. Sweden
7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.4.8. Norway
7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5. Asia Pacific
7.5.1. Japan
7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.2. China
7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.3. India
7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.4. Australia
7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.5. Thailand
7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.5.6. South Korea
7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6. Latin America
7.6.1. Brazil
7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.2. Mexico
7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.6.3. Argentina
7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7. MEA
7.7.1. South Africa
7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.2. Saudi Arabia
7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.3. UAE
7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
7.7.4. Kuwait
7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.2.1. Medtronic
8.2.1.1. Company overview
8.2.1.2. Financial performance
8.2.1.3. Product benchmarking
8.2.1.4. Strategic initiatives
8.2.2. Abbott
8.2.2.1. Company overview
8.2.2.2. Financial performance
8.2.2.3. Product benchmarking
8.2.2.4. Strategic initiatives
8.2.3. Ascensia Diabetes Care
8.2.3.1. Company overview
8.2.3.2. Financial performance
8.2.3.3. Product benchmarking
8.2.3.4. Strategic initiatives
8.2.4. F. Hoffmann-La Roche Ltd.
8.2.4.1. Company overview
8.2.4.2. Financial performance
8.2.4.3. Product benchmarking
8.2.4.4. Strategic initiatives
8.2.5. Bayer AG
8.2.5.1. Company overview
8.2.5.2. Financial performance
8.2.5.3. Product benchmarking
8.2.5.4. Strategic initiatives
8.2.6. LifeScan, Inc.
8.2.6.1. Company overview
8.2.6.2. Financial performance
8.2.6.3. Product benchmarking
8.2.6.4. Strategic Initiatives
8.2.7. Dexcom, Inc.
8.2.7.1. Company overview
8.2.7.2. Financial performance
8.2.7.3. Product benchmarking
8.2.7.4. Strategic initiatives
8.2.8. Sanofi
8.2.8.1. Company overview
8.2.8.2. Financial performance
8.2.8.3. Product benchmarking
8.2.8.4. Strategic initiatives
8.2.9. Insulet Corporation
8.2.9.1. Company overview
8.2.9.2. Financial performance
8.2.9.3. Product benchmarking
8.2.9.4. Strategic initiatives
8.2.10. B. Braun Melsungen AG
8.2.10.1. Company overview
8.2.10.2. Financial performance
8.2.10.3. Product benchmarking
8.2.10.4. Strategic initiatives

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野(医療機器)の最新刊レポート

Grand View Research社の医療機器分野での最新刊レポート

本レポートと同じKEY WORD(diabetes)の最新刊レポート


よくあるご質問


Grand View Research社はどのような調査会社ですか?


グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23 10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る